PriceTracker GLP-1

GLP-1 TV · Patient story · views checked Oct 2026

Retatrutide Explained: The Triple-Agonist After Ozempic and Mounjaro

Patient storyBioavailable25,798 views31:10Apr 2026

Our summary

A patient explains how Ozempic works and what the evidence says, mentioning 1 mg and 2 mg. Side effects mentioned: nausea, vomiting and diarrhea. Also covers food, protein and eating, food noise and cravings and mood and mental health.

One person's experience, in their words. Not medical advice.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Understanding retatrutide
  2. 3:28 The role of GIP signaling
  3. 6:12 The glucagon mechanism
  4. 8:58 Health outcomes and dashboards
  5. 12:45 Interpreting patient outcomes
  6. 13:38 Evidence vs. speculation
  7. 15:54 Phase 2 trial evidence
  8. 16:22 Dosing and escalation

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic, Wegovy, Mounjaro and semaglutide
Doses mentioned
1 mg and 2 mg
Side effects mentioned
nausea, vomiting and diarrhea
Who is speaking
Patient

Find more like it

Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsMood and mental healthExercise and strengthAlcoholHow it worksThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV